| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,658 |
1,544 |
$133K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,126 |
1,062 |
$56K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
232 |
222 |
$20K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
634 |
589 |
$18K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
263 |
254 |
$16K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
698 |
674 |
$15K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
243 |
231 |
$12K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
932 |
888 |
$10K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
215 |
197 |
$5K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
44 |
40 |
$5K |
| 99051 |
|
131 |
126 |
$2K |
| 87428 |
|
20 |
19 |
$1K |
| 94760 |
|
44 |
41 |
$118.95 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
46 |
44 |
$86.88 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
42 |
39 |
$42.15 |
| 99080 |
|
131 |
128 |
$0.00 |
| 99000 |
|
39 |
38 |
$0.00 |